Next Generation News and Research

RSS

NDS Surgical Imaging unveils wireless and visualization technologies for surgical and endoscopy suites

NDS Surgical Imaging (NDSsi) today unveiled breakthrough wireless and visualization technologies for surgical and endoscopy suites, including the ZeroWire® wireless video solution, a 55” Radiance® multi-modality display with built-in ZeroWire technology, and a 24” EndoVue™ value line of single-modality displays.

12 Oct 2009

Buehler Motor relocates and expands its U.S. headquarters

Buehler Motor, Inc. (BMI), a leading international provider of mechatronic drive solutions, has relocated and expanded its U.S. headquarters to allow it to better provide its customers in automotive, aerospace, medical devices, office and building automation with the latest advances in green technology.

12 Oct 2009

Wolverine Venture Fund to participate in Direct Flow Medical's Series C round of financing

Wolverine Venture Fund (WVF), managed by The Samuel Zell & Robert H. Lurie Institute for Entrepreneurial Studies at the University of Michigan Ross School of Business, today announced participation in Direct Flow Medical Inc.'s Series C round of financing. Direct Flow Medical is an emerging medical device company developing a next-generation, catheter based, percutaneous-delivered prosthetic aortic valve.

12 Oct 2009

Crescendo Biologics raises funds to advance the development of its fragment antibody technology platforms

Crescendo Biologics today announces it has raised GBP4.5 million in a seed-funding round to advance the development of its fragment antibody technology platforms. The funding round was led by Sofinnova Partners, a Paris-based venture capital firm, with Aitua, Avlar BioVentures and the Rainbow Seed Fund also participating.

12 Oct 2009

PFCD releases the updated comparison of chronic care provisions contained within health reform bill

The Partnership to Fight Chronic Disease (PFCD) today released an updated comparison of chronic care provisions contained within health reform legislation to reflect the amended Senate Finance Committee proposal. The amended "Chairman's Mark" includes numerous provisions to prevent and manage chronic disease, the top cost driver in health care, as do the two other major pieces of health reform legislation under consideration in Congress.

9 Oct 2009

RXi Pharmaceuticals presents new preclinical data from its advanced RNAi therapeutic platform

RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced the presentation of new preclinical data from its advanced RNAi therapeutic platform at its Annual Investor Event held in New York City on Monday, October 5, 2009.

9 Oct 2009

Save the Children urges world leaders to implement global food security initiative to curb child malnutrition

Although food prices have dropped from last year's record highs, fallout from the financial crisis is driving an increasing number of children into hunger, says Save the Children.

9 Oct 2009

Angiochem to announce clinical study results of ANG1005 drug

Angiochem, Inc. a clinical-stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier to treat brain diseases, announced today that clinical data for its lead drug candidate, ANG1005, for the treatment of brain cancers, as well as data showing how compounds from Angiochem’s Engineered Peptide Compounds (EPiC) platform are capable of crossing the blood-brain barrier will be highlighted at the Society for Neuroscience Annual Meeting in Chicago on October 17-21, 2009.

8 Oct 2009

New research report outlines growth prospects of Biomagnetics Diagnostics

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis, and malaria detection, today announced the Company is the subject of a new research report issued by Emerging Growth Research, LLP.

8 Oct 2009

Hamamatsu to release its NanoZoomer 2.0 series slide scanners

Hamamatsu Corporation has announced the release of its next-generation slide scanners, the NanoZoomer 2.0 series. Operating at nearly twice the speed of the original series, the NanoZoomer 2.0 converts a 20 mm x 20 mm area on a glass slide into a 1.9-gigapixel color image in as little as 1 minute 40 seconds.

8 Oct 2009

New mechanism of bone formation may help fight osteoporosis

The natural cycle of building bone to maintain skeletal strength and then breaking it down for the body's calcium needs is delicately balanced, but diseases like osteoporosis break down too much bone without adequate bone replacement, leading to bone fractures.

8 Oct 2009

BC Cancer Agency scientists find major breakthrough in breast cancer

For the first time in history, BC Cancer Agency scientists in British Columbia, Canada have decoded all of the three billion letters in the DNA sequence of a metastatic lobular breast cancer tumour, a type of breast cancer which accounts for about 10 per cent of all breast cancers, and have found all of the mutations, or "spelling" mistakes that caused the cancer to spread.

8 Oct 2009

Family and population based approaches sheds new light on the potential roles of common and rare forms of human genetic variation

In one of the first studies of its kind, an international team of researchers has uncovered a single-letter change in the genetic code that is associated with autism. The finding, published in the October 8 issue of the journal Nature, implicates a neuronal gene not previously tied to the disorder and more broadly, underscores a role for common DNA variation.

8 Oct 2009

NCI awards $11.5 million grant to UAB for cervical cancer research

The University of Alabama at Birmingham (UAB) Comprehensive Cancer Center has won an $11.5 million grant from the National Cancer Institute (NCI) to explore groundbreaking cervical cancer research, prevention and treatment.

8 Oct 2009

NHGRI awards Geospiza a SBIR grant to develop software systems for detecting rare mutations

Geospiza, Inc., the market leading developer of genetic analysis software, today announced the receipt of a Phase I SBIR grant for “Software Systems for Detecting Rare Mutations” from the National Human Genome Research Institute (1R43HG005297-01).

7 Oct 2009

US Spine introduces Phantom Plus Interbody Fusion System

US Spine® is pleased to announce the launch of the Phantom Plus™ Interbody Fusion System. Phantom Plus provides spine surgeons with next generation instrumentation and implants that offer a compliment to US Spine’s posterior fixation systems. Features include tapered leading edges for easy insertion, a higher degree of doming to more closely match endplate anatomy, anti-migration teeth, and advanced instrumentation for multiple insertion techniques.

7 Oct 2009

CryoValve SG aortic human heart valve receives Humanitarian Use Device designation

CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, today announced that it has received a Humanitarian Use Device (HUD) designation from the Food and Drug Administration (FDA) for its CryoValve® SG aortic human heart valve.

6 Oct 2009

FDA provides 510(k) clearance for Boston Scientific's WallFlex Biliary RX covered stents

Boston Scientific Corporation today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its WallFlex(®) Biliary RX fully and partially covered stents for the palliative treatment of malignant bile duct strictures. The WallFlex Biliary RX uncovered stent was cleared by the FDA in 2006.

6 Oct 2009

Sigma-Aldrich to distribute ThalesNano's CatCart catalyst products globally

Sigma-Aldrich announced today that it has signed a distribution agreement with ThalesNano, the world leader in bench top flow chemistry instruments, the terms of which will see Sigma-Aldrich distribute ThalesNano's complete line of approximately 400 CatCart® catalyst products for flow chemistry solutions on a global basis.

6 Oct 2009

MEF 21 certification for D-Link Xstack DES-3200 switch series

D-Link, the end-to-end computer networking solutions provider for consumer and business, today announced that its xStack® DES-3200 Series was one of the first product lines to receive MEF 21 certification from Iometrix test laboratory, the MEF authorized certification test lab.

6 Oct 2009

Next Generation News and Research

NDS Surgical Imaging unveils wireless and visualization technologies for surgical and endoscopy suites

Buehler Motor relocates and expands its U.S. headquarters

Wolverine Venture Fund to participate in Direct Flow Medical's Series C round of financing

Crescendo Biologics raises funds to advance the development of its fragment antibody technology platforms

PFCD releases the updated comparison of chronic care provisions contained within health reform bill

RXi Pharmaceuticals presents new preclinical data from its advanced RNAi therapeutic platform

Save the Children urges world leaders to implement global food security initiative to curb child malnutrition

Angiochem to announce clinical study results of ANG1005 drug

New research report outlines growth prospects of Biomagnetics Diagnostics

Hamamatsu to release its NanoZoomer 2.0 series slide scanners

New mechanism of bone formation may help fight osteoporosis

BC Cancer Agency scientists find major breakthrough in breast cancer

Family and population based approaches sheds new light on the potential roles of common and rare forms of human genetic variation

NCI awards $11.5 million grant to UAB for cervical cancer research

NHGRI awards Geospiza a SBIR grant to develop software systems for detecting rare mutations

US Spine introduces Phantom Plus Interbody Fusion System

CryoValve SG aortic human heart valve receives Humanitarian Use Device designation

FDA provides 510(k) clearance for Boston Scientific's WallFlex Biliary RX covered stents

Sigma-Aldrich to distribute ThalesNano's CatCart catalyst products globally

MEF 21 certification for D-Link Xstack DES-3200 switch series

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News